白塞综合征

Kural-Seyahi E, Fresko I, Seyahi N, et al. The long-term mortality and morbidity of Behcet's syndrome: a 2-decade outcome survey of 387 patients followed at a dedicated center. Medicine (Baltimore). 2003 Jan;82(1):60-76. 摘要

International Study Group for Behcet's Disease. Criteria for diagnosis of Behcet's disease. Lancet. 1990 May 5;335(8697):1078-80. 摘要

1. Yazici H, Fresko I, Yurdakul S. Behcet's syndrome: disease manifestations, management, and advances in treatment. Nat Clin Pract Rheumatol. 2007 Mar;3(3):148-55. 摘要

2. Behcet H. Uber rezidivierende aphthöse, durch ein Virus Verursachte Geschwure am Mund, am Auge und an den Genitalien. Dermatol Wschr [in German]. 1937;105:1152-7.

3. Sakane T, Takeno M, Suzuki N, et al. Behcet's syndrome. N Engl J Med. 1999 Oct 21;341(17):1284-91. 摘要

4. Fonseca Cardoso A, Rocha-Filho PA, Melo Correa-Lima AR. Neuro-Behçet: differential diagnosis of recurrent meningitis. Rev Med Chil. 2013 Jan;141(1):114-8.全文  摘要

5. Saadoun D, Wechsler B. Behçet's disease. Orphanet J Rare Dis. 2012 Apr 12;7:20.全文  摘要

6. Wechsler B, Sbaï A, Du-Boutin LT, et al. Neurological manifestations of Behçet's disease [in French]. Rev Neurol (Paris). 2002 Oct;158(10 pt 1):926-33. 摘要

7. Yin H, Song Y, Zheng M, et al. Behcet's disease with cerebral artery infarction caused by cerebral arteritis as an early symptom only with elevated interleukin-8. Front Neurol. 2019 Oct 22;10:1102.全文  摘要

8. Kural-Seyahi E, Fresko I, Seyahi N, et al. The long-term mortality and morbidity of Behcet's syndrome: a 2-decade outcome survey of 387 patients followed at a dedicated center. Medicine (Baltimore). 2003 Jan;82(1):60-76. 摘要

9. Calamia KT, Wilson FC, Icen M, et al. Epidemiology and clinical characteristics of Behçet's disease in the US: a population-based study. Arthritis Rheum. 2009 May 15;61(5):600-4.全文  摘要

10. Yurdakul S, Tuzuner N, Yurdakul I, et al. Gastrointestinal involvement in Behcet's syndrome: a controlled study. Ann Rheum Dis. 1996 Mar;55(3):208-10. 摘要

11. Yazici Y, Adler NM. Clinical manifestations and ethnic background of patients with Behcet's syndrome in a US cohort. Arthritis Rheum. 2007;56(suppl):S502.

12. Gul A, Hajeer AH, Worthington J, et al. Linkage mapping of a novel susceptibility locus for Behcet's syndrome to chromosome 6p22-23. Arthritis Rheum. 2001 Nov;44(11):2693-6. 摘要

13. Direskeneli H. Autoimmunity vs autoinflammation in Behcet's syndrome: do we oversimplify a complex disorder? Rheumatology (Oxford). 2006 Dec;45(12):1461-5. 摘要

14. Tunc R, Keyman E, Melikoglu M, et al. Target organ associations in Turkish patients with Behcet's syndrome: a cross sectional study by exploratory factor analysis. J Rheumatol. 2002 Nov;29(11):2393-6. 摘要

15. Bird Stewart JA. Genetic analysis of families of patients with Behçet's syndrome: data incompatible with autosomal recessive inheritance. Ann Rheum Dis. 1986 Apr;45(4):265-8.全文  摘要

16. Fresko I, Soy M, Hamuryudan V, et al. Genetic anticipation in Behcet's syndrome. Ann Rheum Dis. 1998 Jan;57(1):45-8. 摘要

17. International Study Group for Behcet's Disease. Criteria for diagnosis of Behcet's disease. Lancet. 1990 May 5;335(8697):1078-80. 摘要

18. Hamuryudan V, Er T, Seyahi E, et al. Pulmonary artery aneurysms in Behcet's syndrome. Am J Med. 2004 Dec 1;117(11):867-70. 摘要

19. Akman-Demir G, Serdaroglu P, Tasçi B. Clinical patterns of neurological involvement in Behçet's disease: evaluation of 200 patients. The Neuro-Behçet Study Group. Brain. 1999 Nov;122 (Pt 11):2171-82.全文  摘要

20. Hatemi G, Christensen R, Bang D, et al. 2018 update of the EULAR recommendations for the management of Behçet's syndrome. Ann Rheum Dis. 2018 Jun;77(6):808-18.全文  摘要

21. Ohno S, Ohguchi M, Hirose S, et al. Close association of HLA-Bw51 with Behçet's disease. Arch Ophthalmol. 1982 Sep;100(9):1455-8. 摘要

22. de Menthon M, Lavalley MP, Maldini C, et al. HLA-B51/B5 and the risk of Behçet's disease: a systematic review and meta-analysis of case-control genetic association studies. Arthritis Rheum. 2009 Oct 15;61(10):1287-96.全文  摘要

23. Fresko I, Ugurlu S, Ozbakir F, et al. Anti-Saccharomyces cerevisiae antibodies (ASCA) in Behcet's syndrome. Clin Exp Rheumatol. 2005 Jul-Aug;23(4 suppl 38):S67-70. 摘要

24. Fresko I, Yazici H. Treatment strategies for Behcet's disease. Expert Opin Pharmacother. 2008 Dec;9(18):3211-9. 摘要

25. Hamuryudan V, Hatemi G, Tascilar K, et al. Colchicine in Behcet syndrome: a longterm survey of patients in a controlled trial. J Rheumatol. 2014 Apr;41(4):735-8. 摘要

26. Hatemi G, Mahr A, Ishigatsubo Y, et al. Trial of apremilast for oral ulcers in Behçet's syndrome. N Engl J Med. 2019 Nov 14;381(20):1918-28.全文  摘要

27. Atienza-Mateo B, Martín-Varillas JL, Calvo-Río V, et al. Comparative study of infliximab versus adalimumab in refractory uveitis due to Behçet's disease: national multicenter study of 177 cases. Arthritis Rheumatol. 2019 Dec;71(12):2081-9.全文  摘要

28. Giardina A, Ferrante A, Ciccia F, et al. One year study of efficacy and safety of infliximab in the treatment of patients with ocular and neurological Behçet's disease refractory to standard immunosuppressive drugs. Rheumatol Int. 2011 Jan;31(1):33-7. 摘要

29. Zeydan B, Uygunoglu U, Saip S, et al. Infliximab is a plausible alternative for neurologic complications of Behçet disease. Neurol Neuroimmunol Neuroinflamm. 2016 Jul 8;3(5):e258.全文  摘要

30. Vallet H, Riviere S, Sanna A, et al. Efficacy of anti-TNF alpha in severe and/or refractory Behçet's disease: multicenter study of 124 patients. J Autoimmun. 2015 Aug;62:67-74. 摘要

31. Emmi G, Bettiol A, Silvestri E, et al. Vascular Behçet's syndrome: an update. Intern Emerg Med. 2019 Aug;14(5):645-52. 摘要

32. Emmi G, Vitale A, Silvestri E, et al. Adalimumab-based treatment versus disease-modifying antirheumatic drugs for venous thrombosis in Behçet's syndrome: a retrospective study of seventy patients with vascular involvement. Arthritis Rheumatol. 2018 Sep;70(9):1500-7.全文  摘要

33. Mirouse A, Barete S, Desbois AC, et al. Long-term outcome of ustekinumab therapy for Behçet's disease. Arthritis Rheumatol. 2019 Oct;71(10):1727-32. 摘要